Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell ...
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized ...
A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...
The identification of CD8+ TIGR cells yields new insights into organ-specific immune regulation and potential therapeutics for inflammatory bowel disease.
Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...
From why it was created to whether it’s alive, here’s what to know about SpudCell, the latest advance in synthetic biology. By K. R. Callaway SpudCell is a synthetic cell made by scientists at the ...
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward ...
The Supreme Court's conservative majority took a sledgehammer to much of the federal government's regulatory structure Monday, striking down almost all the limits that Congress — and the courts — had ...
Mast cells (MCs), as innate immune cells residing in cutaneous tissues, serve as critical mediators in the cross-talk between the neuroendocrine and immune systems. Upon activation by internal or ...
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas. Long-term results and curative potential remain uncertain. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results